Literature DB >> 6197737

Composition and structure of lipopolysaccharides from Pseudomonas aeruginosa.

S G Wilkinson.   

Abstract

Lipopolysaccharides from Pseudomonas aeruginosa seem to have the same general architecture as those from enterobacteria. Points of difference include the fatty acid composition and the unusually high degree of phosphorylation (triphosphate residues have been detected). The outer region of the core oligosaccharides is also distinctive; its components are D-glucose, L-rhamnose, D-galactosamine, and possibly L-alanine. Lipopolysaccharide preparations contain a relatively low proportion of complete (S-form) molecules, but in some cases contain a significant proportion of molecules that have a single O-specific repeating unit attached to the core oligosaccharide. The O-specific side chains are typically rich in amino sugars, including novel types. Components identified so far are 2-amino-2-deoxyglucose, 2-amino-2-deoxygalactose, 2-amino-2,6-dideoxyglucose, 2-amino-2,6-dideoxygalactose, 2-amino-2-deoxygalacturonic acid, 2,4-diamino-2,4,6-trideoxyglucose, 2,3-diamino-2,3-dideoxyhexuronic acids (with the D-gluco-, D-manno-, and L-gulo-configurations), and 2,3-(2-methyl-2-imidazolino-5,4)-2,3-dideoxymannuronic acid. In some cases, polymeric material enriched in neutral sugars can be isolated from the O-specific fractions of partly degraded polysaccharides.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6197737     DOI: 10.1093/clinids/5.supplement_5.s941

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  28 in total

1.  Growth-dependent alterations in production of serotype-specific and common antigen lipopolysaccharides in Pseudomonas aeruginosa PAO1.

Authors:  E J McGroarty; M Rivera
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

2.  Functionally active monoclonal antibody that recognizes an epitope on the O side chain of Pseudomonas aeruginosa immunotype-1 lipopolysaccharide.

Authors:  B J Stoll; M Pollack; L S Young; N Koles; R Gascon; G B Pier
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

Review 3.  Epidemiological typing of Pseudomonas aeruginosa.

Authors:  T L Pitt
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-04       Impact factor: 3.267

4.  Antibody Binding to the O-Specific Antigen of Pseudomonas aeruginosa O6 Inhibits Cell Growth.

Authors:  Gabrielle Richard; C Roger MacKenzie; Kevin A Henry; Evgeny Vinogradov; J Christopher Hall; Greg Hussack
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

5.  Pseudomonas aeruginosa lipopolysaccharide binds galectin-3 and other human corneal epithelial proteins.

Authors:  S K Gupta; S Masinick; M Garrett; L D Hazlett
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

6.  A major autolysin of Pseudomonas aeruginosa: subcellular distribution, potential role in cell growth and division and secretion in surface membrane vesicles.

Authors:  Z Li; A J Clarke; T J Beveridge
Journal:  J Bacteriol       Date:  1996-05       Impact factor: 3.490

7.  Structural elucidation of the lipopolysaccharide core region of the O-chain-deficient mutant strain A28 from Pseudomonas aeruginosa serotype 06 (International Antigenic Typing Scheme).

Authors:  H Masoud; I Sadovskaya; T de Kievit; E Altman; J C Richards; J S Lam
Journal:  J Bacteriol       Date:  1995-12       Impact factor: 3.490

8.  Interaction of gentamicin with the A band and B band lipopolysaccharides of Pseudomonas aeruginosa and its possible lethal effect.

Authors:  J L Kadurugamuwa; J S Lam; T J Beveridge
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

9.  Variability in Pseudomonas aeruginosa lipopolysaccharide expression during crude oil degradation.

Authors:  R Sean Norman; Roberto Frontera-Suau; Pamela J Morris
Journal:  Appl Environ Microbiol       Date:  2002-10       Impact factor: 4.792

10.  Molecular basis for the increased polymyxin susceptibility of Klebsiella pneumoniae strains with under-acylated lipid A.

Authors:  Tony Velkov; Rachel L Soon; Pei L Chong; Johnny X Huang; Matthew A Cooper; Mohammad A K Azad; Mark A Baker; Philip E Thompson; Kade Roberts; Roger L Nation; Abigail Clements; Richard A Strugnell; Jian Li
Journal:  Innate Immun       Date:  2012-09-24       Impact factor: 2.680

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.